Clinical Trial Details
— Status: Recruiting
Administrative data
NCT number |
NCT05529121 |
Other study ID # |
1616612 |
Secondary ID |
|
Status |
Recruiting |
Phase |
|
First received |
|
Last updated |
|
Start date |
December 3, 2021 |
Est. completion date |
December 31, 2025 |
Study information
Verified date |
September 2022 |
Source |
Corporal Michael J. Crescenz VA Medical Center |
Contact |
Madison Smith |
Phone |
215-823-5800 |
Email |
madison.smith1[@]va.gov |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Under a grant from the Department of Defense's PD program, Dr. Morley's is investigating new
approaches that 1) use "gamification"- applying rules of games like point scoring, achieving
silver, gold or platinum levels and competition-- to increase physical activity in PD; 2)
identify whether certain PD patient respond differently to gamification interventions than
others.; 3) use readily and commercially available (including Fitbits) digital health
technologies to perform all study activities remotely and enable a "touchless" study where
patients don't have to come in person for any studies visits. The study is underway and
actively recruiting.
Description:
Objectives(s): To investigate whether: 1) Protocols using gamification to increase physical
activity in patients with PD employing remote intervention and assessment will be feasible
and acceptable to participants; 2) Individual NMS will predict responsiveness to a
gamification intervention targeting physical activity levels-facilitating a personalized
approach in future efficacy studies; 3) Changes in physical activity will be associated with
changes in motor symptoms, measured using the wearable Parkinson's Kinetograph (PKG)
Research Design: This is a prospective observational study. Using administrative databases
and review of medical records, we will identify and remotely enroll 85 Veterans with PD on
stable medication regimens into a protocol including: 1) Two week assessment of baseline
activity using Fitbits; 2) a 6-week gamification intervention program targeted to a 20%
increase in average daily steps; 3) 4-week follow-up period after the intervention. At
baseline and following the gamification period, we will assess a variety of NMS in PD using
validated questionnaires. PD motor symptoms will be assessed using the PKG (bradykinesia and
motor scores) at baseline, at the end of the gamification program and after follow-up..
Methodology: All survey assessments, activity monitoring and administration of the
gamification intervention will be conducted remotely using Way to Health, a web-based digital
health platform developed at the University of Pennsylvania. Participants will complete
surveys at the beginning of the study that quantify various sociodemographic, clinical, and
geographical factors using the Way to Health platform. All participants will be mailed a
Fitbit Inspire, a wearable activity tracker to be worn on the hip for 30 days to record daily
steps. Participatiants will also be mailed a Parkinson's Kinetograph (PKG) to wear at
baseline, at the end of the gamification program and after follow-up. Participants will sync
their Fitbit data to the Way to Health platform, that has been used for previous clinical
trials at the CMCVAMC. Statistical analysis: Aim 1: We will assess feasibility of the
intervention using descriptive statistics; Aim 2: We will examine the association of baseline
disease characteristics with response to the intervention using linear mixed effects models
Aim 3: We will examine the association between changes in physical activity and motor
symptoms using linear mixed effects models.
Clinical relationships: Exercise and physical activity are potential "silver bullets" in the
treatment of Parkinson's disease (PD). Exercise has efficacy as a symptomatic and potentially
disease-modifying therapy. However, low levels of physical activity in community-dwelling
populations with PD demonstrate that exercise is not yet being used as an effective therapy.
Interventions to increase activity levels of PD patients under real world conditions will
have tremendous and immediate translational impact. Personalized strategies using digital
health technology to increase physical activity would be highly scalable, improving the
symptoms and lives of countless people living with PD The COVID19 pandemic halted most
human-subjects research because of the need for face to face recruitment and visits.
Traditional models of face to face recruitment and assessment are unlikely to be viable
during the funding period for the proposed studies, and, perhaps, beyond. Approaches to
recruitment and assessment that circumvent the need for face to face contact will have high
impact.
Impact/Significance: Personalized strategies using digital health technology to increase
physical activity would be highly scalable, improving the symptoms and lives of countless
people living with PD.